Sigman. research

Last changed on 14 April 2021 - 11:53

“When the covid pandemic hit us, I thought about the idea of using MLS® on patients affected by the virus. We see great results in acute inflammation resulting from joint damage and this was the natural connection.”

This was how the experience of Dr Scott Sigman began, orthopaedic surgeon in Boston and Chief Medical Officer at OrthoLazer Orthopedic Centers.